Early detection of hepatitis C virus infection using a new combined antigen-antibody detection assay: potential use in HIV co-infected individuals;Intérêt d'un nouveau test combiné antigène-anticorps pour le dépistage de l'infection par le virus de l'hépatite C : réduction de la fenêtre sérologique au cours de l'hépatite C aiguë chez le sujet co-infecté par le VIH

Pathologie Biologie

Volumn 54, Issue 10, 2006, Pages 578-586

  Schnuriger, A ^a   Dominguez, S ^a   Valantin, M A ^a   Tubiana, R ^a   Duvivier, C ^a   Ghosn, J ^a   Simon, A ^a   Katlama, C ^a   Thibault, V ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antigen antibody assay; Diagnosis; Hepatitis C; HIV co infection; Seronegative window

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FREEZING; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SERUM; VIRUS REPLICATION;

ANTIGEN-ANTIBODY COMPLEX; EVOLUTION, MOLECULAR; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; RNA, VIRAL;

EID: 33751308135     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2006.07.046     Document Type: Article

References (28)

1. Global_Burden_of_Hepatitis_C_Working_Group. Global burden of disease (GBD) for hepatitis C. J. Clin. Pharmacol. 44 1 (2004) 20-29
2. Pawlotsky J.M. Use and interpretation of virological tests for hepatitis C. Hepatology 36 5 Suppl 1 (2002) S65-S73
3. Barrera J.M., Francis B., Ercilla G., Nelles M., Achord D., Darner J., et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation Elisa. Vox Sang. 68 1 (1995) 15-18
4. Tobler L.H., Stramer S.L., Lee S.R., Masecar B.L., Peterson J.E., Davis E.A., et al. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening. Transfusion 43 10 (2003) 1452-1459
5. Gerlach J.T., Diepolder H.M., Zachoval R., Gruener N.H., Jung M.C., Ulsenheimer A., et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125 1 (2003) 80-88
6. Laperche S., Le Marrec N., Simon N., Bouchardeau F., Defer C., Maniez-Montreuil M., et al. A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection. Transfusion 43 7 (2003) 958-962
7. Nubling C.M., Unger G., Chudy M., Raia S., and Lower J. Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase. Transfusion 42 8 (2002) 1037-1045
8. Bouvier-Alias M., Patel K., Dahari H., Beaucourt S., Larderie P., Blatt L., et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36 1 (2002) 211-218
9. Veillon P., Payan C., Picchio G., Maniez-Montreuil M., Guntz P., and Lunel F. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J. Clin. Microbiol. 41 7 (2003) 3212-3220
10. Ansaldi F., Bruzzone B., Testino G., Bassetti M., Gasparini R., Crovari P., et al. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. J. Viral Hepat. 13 1 (2006) 5-10
11. Hmaied F., Ben Mamou M., Arrouji Z., Slim A., and Ben Redjeb S. Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase. Pathol. Biol. (Paris) (2006)
12. Laperche S., Elghouzzi M.H., Morel P., Asso-Bonnet M., Le Marrec N., Girault A., et al. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?. Transfusion 45 12 (2005) 1965-1972
13. Laperche S., Le Marrec N., Girault A., Bouchardeau F., Servant-Delmas A., Maniez-Montreuil M., et al. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J. Clin. Microbiol. 43 8 (2005) 3877-3883
14. Ridzon R., Gallagher K., Ciesielski C., Ginsberg M.B., Robertson B.J., Luo C.C., et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N. Engl. J. Med. 336 13 (1997) 919-922
15. Lamoril J., Lunel F., Laurent-Puig P., Defer C., Loiseau P., Lefrere J.J., et al. Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. Group d'études moléculaires des hépatites (GEMHEP). J. Hepatol. 21 1 (1994) 133-134
16. Pawlotsky J.M., Bastie A., Pellet C., Remire J., Darthuy F., Wolfe L., et al. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J. Clin. Microbiol. 34 1 (1996) 80-83
17. Sandres-Saune K., Deny P., Pasquier C., Thibaut V., Duverlie G., and Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J. Virol. Methods 109 2 (2003) 187-193
18. Ghosn J., Pierre-Francois S., Thibault V., Duvivier C., Tubiana R., Simon A., et al. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med. 5 4 (2004) 303-306
19. Bukh J., Purcell R.H., and Miller R.H. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad. Sci. USA 91 17 (1994) 8239-8243
20. Alter M.J., Kuhnert W.L., and Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 52 RR-3 (2003) 1-13 (15; quiz CE1-4)
21. Busch M.P., Kleinman S.H., Jackson B., Stramer S.L., Hewlett I., and Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 40 2 (2000) 143-159
22. Kolk D.P., Dockter J., Linnen J., Ho-Sing-Loy M., Gillotte-Taylor K., McDonough S.H., et al. Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay. J. Clin. Microbiol. 40 5 (2002) 1761-1766
23. Morand P., Dutertre N., Minazzi H., Burnichon J., Pernollet M., Baud M., et al. Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury. Clin. Infect. Dis. 33 5 (2001) 727-729
24. Vaghefi P., Roque-Afonso A.M., and Dussaix E. Rapid seroreversion following spontaneous recovery of acute hepatitis C in an HIV infected patient. Pathol. Biol. (Paris) (2006)
25. Ly T.D., Laperche S., Brennan C., Vallari A., Ebel A., Hunt J., et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J. Virol. Methods 122 2 (2004) 185-194
26. Icardi G., Ansaldi F., Bruzzone B.M., Durando P., Lee S., de Luigi C., et al. Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen. J. Clin. Microbiol. 39 9 (2001) 3110-3114
27. Krajden M., Shivji R., Gunadasa K., Mak A., McNabb G., Friesenhahn M., et al. Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection. J. Clin. Microbiol. 42 9 (2004) 4054-4059
28. Dominguez S., Ghosn J., Valantin M.A., Schnuriger A., Simon A., Bonnard P., et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS 20 8 (2006) 1157-1161